Vancouver, Canada-based InMed Pharmaceuticals is a preclinical biotech company that specializes in developing novel drug therapies by manufacturing cannabinoids with the potential to have a therapeutic effect on specific diseases.
Marijuana Industry
How InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Breakthrough Biosynthesis Works - Video
There's been a lot of focus lately on InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) breakthrough proprietary biosynthesis technology, and how it could unlock a $6 Billion Industry.
Cannabinoid Biosynthesis Poised as Potential Game-Changer in Drug Development
As the marijuana market continues its widespread growth, researchers remain merely at the threshold of exploring the manifold potential medical applications of cannabis.
Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market
The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020.
Rapidly Changing Cannabis Industry Offers Plenty of Growth in Horizontal Markets
From Main Street to Wall Street, the cannabis industry is branching out into a variety of business opportunities for not only the key players involved but smaller startup firms as well.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Technology Targets Many Massive Markets
The innovative biotech has developed a lipid-based system that delivers bioactive compounds more efficiently.
Canopy Growth Corp.: Does Profitability Really Matter Right Now?
Shares of Canopy Growth Corp. (TSX:WEED) took a dip after reporting underwhelming fourth-quarter results that clearly didn’t impress the general public. Although the company saw Q4 revenue soar 191% year over year to $14.7 million, many analysts were looking for revenue to grow to at least $16.4 million. But that is not really a problem.
Manitoba First Nation makes major investment in pot company
CBC News has learned that the Opaskwayak Cree Nation in Manitoba has taken a major stake in a medical marijuana company, with an eye to becoming a big player in the sale of pot once it becomes legal.
Cannabinoid Consumer Market Booming as CBD Enjoys Growth in Public Sentiment
As the cannabis industry continues to flourish, many publicly traded companies are finding ample opportunities to thrive.
Singlepoint, Inc. (SING) CEO Discusses Elizabeth Warren’s Cannabis Banking Proposal on MoneyTV with Donald Baillargeon
Before the opening bell, Singlepoint, Inc. (OTC: SING) was announced as a featured company on this week’s episode of MoneyTV with Donald Baillargeon.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product.
DOJA Cannabis Company Provides Production Update
DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce that we commenced cultivating our first cannabis strains in July and that the plants have taken well to their new home at DOJA's production facility in British Columbia's Okanagan Valley.
Copy of InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology
If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind.
Singlepoint, Inc. (SING) CEO Greg Lambrecht Reveals High Points of Convectium Acquisition
There should be “more funding on the way,” according to Singlepoint CEO Greg Lambrecht, who discussed the acquisition in a recent episode of MoneyTV with Donald Baillargeon.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology
If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind.